Canada
I am a Ph.D. student specializing in Molecular Genetics, with a strong foundation in advanced laboratory techniques. My expertise includes genome-wide CRISPR screening, fluorometric imaging, PCR, western blotting, high-throughput, high-content drug screening, and embryonic stem cell culturing. Through my research, I continually strive to contribute to cutting-edge scientific discoveries and innovations in the field.
Vice President of Student Life, Molecular Genetics Graduate Student Association Executive Committee
Organizing events led by and with a focus on international students and advocating for international students at the University of Toronto, including financial, social, and cultural issues.
Applying genome-wide CRISPR screens and in vivo mouse models to uncover novel endogeneous sources of DNA double-strand breaks that contribute to neurodegenerative disorders.
Performed high-content phenotypic screens of synthetic compounds and used chemical genomics to uncover novel mechanisms of cancer stem cell biology. I also applied single-cell RNA-sequencing analysis along with clinical efficacy data of 101 current oncology drugs to identify the correlation between drugs' cancer stem cell selectivity and clinical efficacy.
StemImage aims to address challenges commonly faced by research labs conducting phenotypic screening in drug discovery. Traditional methods are often costly and time-intensive, with labs relying on expensive antibodies for cell staining or lineage tracking and labor-intensive screening experiments. To overcome these obstacles, StemImage focuses on developing a computational solution that offers a more efficient and cost-effective alternative to antibody-based staining for image classification in drug discovery.